Hantavirus-infection Confers Resistance to Cytotoxic Lymphocyte-Mediated Apoptosis

PLoS Pathogens

Volumn 9, Issue 3, 2013, Pages

  Gupta, Shawon ^a,b   Braun, Monika ^c   Tischler, Nicole D ^d   Stoltz, Malin ^a,b   Sundström, Karin B ^a,b   Björkström, Niklas K ^c   Ljunggren, Hans Gustaf ^c   Klingström, Jonas ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Fundacion Ciencia para la Vida   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GRANZYME B; NUCLEOCAPSID PROTEIN;

APOPTOSIS; ARTICLE; CELL ISOLATION; CELL KILLING; CYTOTOXIC LYMPHOCYTE; DEGRANULATION; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HANTAVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NATURAL KILLER CELL; NICK END LABELING; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; CASPASE 3; CASPASE INHIBITORS; CELL DEGRANULATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY TESTS, IMMUNOLOGIC; GRANZYMES; HANTAVIRUS; HANTAVIRUS INFECTIONS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KILLER CELLS, NATURAL; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC;

HANTAVIRUS;

EID: 84875978198     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003272     Document Type: Article

References (52)

1. Schönrich G, Rang A, Lütteke N, Raftery MJ, Charbonnel N, et al. (2008) Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev 225: 163-189.
2. Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, et al. (2003) Hantavirus infections in Europe. Lancet Infect Dis 3: 653-661.
3. Geisbert TW, Jahrling PB, (2004) Exotic emerging viral diseases: progress and challenges. Nat Med 10: S110-121.
4. Mackow ER, Gavrilovskaya IN, (2009) Hantavirus regulation of endothelial cell functions. Thromb Haemost 102: 1030-1041.
5. Klingström J, Ahlm C, (2011) Hantavirus protein interactions regulate cellular functions and signaling responses. Expert Rev Anti Infect Ther 9: 33-47.
6. Terajima M, Ennis FA, (2011) T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses 3: 1059-1073.
7. Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, et al. (2004) Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 172: 3297-3304.
8. Lindgren T, Ahlm C, Mohamed, Evander M, Ljunggren HG, et al. (2011) Longitudinal analysis of the human T cell response during acute hantavirus infection. J Virol 85: 10252-10260.
9. Björkström NK, Lindgren T, Stoltz M, Fauriat C, Braun M, et al. (2011) Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 208: 13-21.
10. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, et al. (1994) Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 330: 949-955.
11. Nolte KB, Feddersen RM, Foucar K, Zaki SR, Koster FT, et al. (1995) Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Human Pathol 26: 110-120.
12. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, et al. (1995) Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146: 552-579.
13. Lieberman J, (2003) The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 3: 361-370.
14. Chowdhury D, Lieberman J, (2008) Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 26: 389-420.
15. Bryceson YT, March ME, Ljunggren HG, Long EO, (2006) Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 214: 73-91.
16. Lanier LL, (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495-502.
17. Bryceson YT, Fauriat C, Nunes JM, Wood SM, Björkström NK, et al. (2010) Functional analysis of human NK cells by flow cytometry. Methods Mol Biol 612: 335-353.
18. Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, et al. (2008) A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26: 127-132.
19. Manns J, Daubrawa M, Driessen S, Paasch F, Hoffmann N, et al. (2011) Triggering of a novel intrinsic apoptosis pathway by the kinase inhibitor staurosporine: activation of caspase-9 in the absence of Apaf-1. FASEB J 25: 3250-3261.
20. Best SM, (2008) Viral subversion of apoptotic enzymes: escape from death row. Annu Rev Microbiol 62: 171-192.
21. Ewen CL, Kane KP, Bleackley RC, (2012) A quarter century of granzymes. Cell Death Differ 19: 28-35.
22. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, et al. (1992) Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69: 597-604.
23. Quan LT, Caputo A, Bleackley RC, Pickup DJ, Salvesen GS, (1995) Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J Biol Chem 270: 10377-10379.
24. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, et al. (1997) Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J Biol Chem 272: 7797-7800.
25. Benedict CA, Norris PS, Ware CF, (2002) To kill or be killed: viral evasion of apoptosis. Nat Immunol 3: 1013-1018.
26. Iannello A, Debbeche O, Martin E, Attalah LH, Samarani S, et al. (2006) Viral strategies for evading antiviral cellular immune responses of the host. J Leukoc Biol 79: 16-35.
27. Lamkanfi M, Dixit VM, (2010) Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8: 44-54.
28. Van Domselaar R, Bovenschen N, (2011) Cell death-independent functions of granzymes: hit viruses where it hurts. Rev Med Virol 21: 301-314.
29. Andrade F, Bull HG, Thornberry NA, Ketner GW, Casciola-Rosen LA, et al. (2001) Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death. Immunity 14: 751-761.
30. Sebbagh M, Hamelin J, Bertoglio J, Solary E, Bréard J, (2005) Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J Exp Med 201: 465-471.
31. Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC, (2003) Granzyme B: a natural born killer. Immunol Rev 193: 31-38.
32. Rousalova I, Krepela E, (2010) Granzyme B-induced apoptosis in cancer cells and its regulation. Int J Oncol 37: 1361-1378.
33. Andrade F, (2010) Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state. Immunol Rev 235: 128-146.
34. Marcet-Palacios M, Duggan BL, Shostak I, Barry M, Geskes T, et al. (2011) Granzyme B inhibits vaccinia virus production through proteolytic cleavage of eukaryotic initiation factor 4 gamma 3. PLoS Pathog 7: e1002447.
35. Blink EJ, Jiansheng Z, Hu W, Calanni ST, Trapani JA, et al. (2005) Interaction of the nuclear localizing cytolytic granule serine protease granzyme B with importin α or β: modulation by the serpin inhibitor PI-9. J Cell Biochem 95: 598-610.
36. Taylor SL, Frias-Staheli N, García-Sastre A, Schmaljohn CS, (2009) Hantaan virus nucleocapsid protein binds to importin α proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. J Virol 83: 1271-1279.
37. Taylor SL, Krempel RL, Schmaljohn CS, (2009) Inhibition of TNF-alpha-induced activation of NF-kappaB by hantavirus nucleocapsid proteins. Ann N Y Acad Sci 1171: E86-93.
38. Safronetz D, Hegde NR, Ebihara H, Denton M, Kobinger GP, et al. (2009) Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with Andes virus. J Virol 83: 7285-7295.
39. Van Epps HL, Schmaljohn CS, Ennis FA, (1999) Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J Virol 73: 5301-5308.
40. Van Epps HL, Terajima M, Mustonen J, Arstila TP, Corey EA, et al. (2002) Long-lived memory T lymphocyte responses after hantavirus infection. J Exp Med 196: 579-588.
41. Bryceson YT, Ljunggren HG, (2007) Lymphocyte effector functions: armed for destruction? Curr Opin Immunol 19: 337-338.
42. Klingström J, Hardestam J, Stoltz M, Zuber B, Lundkvist Å, et al. (2006) Loss of cell membrane integrity in Puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J Virol 80: 8279-8282.
43. Marcotic A, Hensley L, Geisbert T, Spik K, Schmaljohn C, (2003) Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. J Gen Virol 84: 2197-2202.
44. Hammerbeck CD, Hooper JW, (2011) T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome. J Virol 85: 9929-9944.
45. Shrivastava-Ranjan P, Rollin PE, Spiropoulou CF, (2010) Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J Virol 84: 11227-11234.
46. Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER, (2008) Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol 82: 5797-5806.
47. Manigold T, Mori A, Graumann R, Llop E, Simon V, et al. (2010) Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by Andes hantavirus. PLoS Pathog 6: e1000779.
48. Stoltz M, Klingström J, (2010) Alpha/Beta interferon (IFN-α/β)-independent induction of IFN-λ1 (interleukin-29) in response to Hantaan virus infection. J Virol 84: 9140-9148.
49. Tischler ND, Rosemblatt M, Valenzuela PD, (2008) Characterization of cross-reactive and serotype-specific epitopes on the nucleocapsid proteins of hantaviruses. Virus Res 135: 1-9.
50. Klingström J, Maljkovic I, Zuber B, Rollman E, Kjerrström A, et al. (2004) Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge. Vaccine 22: 4029-4034.
51. Sundström KB, Stoltz M, Lagerqvist N, Lundkvist Å, Nemirov K, et al. (2011) Characterization of two substrains of Puumala virus that show phenotypes that are different from each other and from the original strain. J Virol 85: 1747-1756.
52. Hardestam J, Klingström J, Mattsson K, Lundkvist Å, (2005) HFRS causing hantaviruses do not induce apoptosis in confluent Vero E6 and A-549 cells. J Med Virol 76: 234-240.